{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:46:27Z","timestamp":1791585987624,"version":"4.3.4"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanxi Provincial Basic Research Program","award":["202303021221191"],"award-info":[{"award-number":["202303021221191"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02448-x","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:33:07Z","timestamp":1759408387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["\u200b\u200bThe immune microenvironment of pathogen-associated cancers and current clinical therapeutics"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiao-Yu","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Yin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"6","key":"2448_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/biology10060533","volume":"10","author":"MNA Hatta","year":"2021","unstructured":"Hatta MNA, Mohamad Hanif EA, Chin S-F, Neoh H. -m. Pathogens and carcinogenesis: a review. Biology. 2021;10(6):533.","journal-title":"Biology"},{"issue":"1","key":"2448_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/cas.13443","volume":"109","author":"JI Yasunaga","year":"2018","unstructured":"Yasunaga JI, Matsuoka M. Oncogenic spiral by infectious pathogens: Cooperation of multiple factors in cancer development. Cancer Sci. 2018;109(1):24\u201332.","journal-title":"Cancer Sci"},{"issue":"1","key":"2448_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","volume":"120","author":"NA Giraldo","year":"2019","unstructured":"Giraldo NA, Sanchez-Salas R, Peske JD, Vano Y, Becht E, Petitprez F, Validire P, Ingels A, Cathelineau X, Fridman WH. The clinical role of the TME in solid cancer. Br J Cancer. 2019;120(1):45\u201353.","journal-title":"Br J Cancer"},{"issue":"1","key":"2448_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41467-022-28479-2","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Ge J, Wang Y, Xiong F, Guo J, Jiang X, Zhang L, Deng X, Gong Z, Zhang S. EBV MiRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1. Nat Commun. 2022;13(1):866.","journal-title":"Nat Commun"},{"issue":"1","key":"2448_CR5","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1038\/s41467-023-38407-7","volume":"14","author":"DW-T Lim","year":"2023","unstructured":"Lim DW-T, Kao H-F, Suteja L, Li CH, Quah HS, Tan DS-W, Tan S-H, Tan E-H, Tan W-L, Lee JN. Clinical efficacy and biomarker analysis of dual PD-1\/CTLA-4 Blockade in recurrent\/metastatic EBV-associated nasopharyngeal carcinoma. Nat Commun. 2023;14(1):2781.","journal-title":"Nat Commun"},{"issue":"1","key":"2448_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12885-023-11804-3","volume":"24","author":"J Li","year":"2024","unstructured":"Li J, Chen H, Bai L, Tang H. Identification of cd8\u2009+\u2009t-cell exhaustion signatures for prognosis in hbv-related hepatocellular carcinoma patients by integrated analysis of single-cell and bulk rna-sequencing. BMC Cancer. 2024;24(1):53.","journal-title":"BMC Cancer"},{"issue":"3","key":"2448_CR7","doi-asserted-by":"publisher","first-page":"e1694","DOI":"10.1038\/cddis.2015.42","volume":"6","author":"B Ye","year":"2015","unstructured":"Ye B, Liu X, Li X, Kong H, Tian L, Chen Y. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death Dis. 2015;6(3):e1694\u20131694.","journal-title":"Cell Death Dis"},{"key":"2448_CR8","doi-asserted-by":"crossref","unstructured":"Chen S, Yao C, Tian N, Zhang C, Chen Y, Wang X, Jiang Y, Zhang T, Zeng T, Song Y. The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer. Cancer Med 2024;13(17):e70154.","DOI":"10.1002\/cam4.70154"},{"key":"2448_CR9","doi-asserted-by":"crossref","unstructured":"Milotay G, Little M, Watson RA, Muldoon D, MacKay S, Kurioka A, Tong O, Taylor CA, Nassiri I, Webb L. M. CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint Blockade. Nat Med. 2025;31(7):2350\u201364.","DOI":"10.1038\/s41591-025-03647-1"},{"issue":"2","key":"2448_CR10","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3892\/ol.2015.3295","volume":"10","author":"D Song","year":"2015","unstructured":"Song D, Li H, Li H, Dai J. Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. Oncol Lett. 2015;10(2):600\u20136.","journal-title":"Oncol Lett"},{"issue":"2","key":"2448_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.15430\/JCP.2021.26.2.118","volume":"26","author":"K Cho","year":"2021","unstructured":"Cho K, Lee HG, Piao J-Y, Kim S-J, Na H-K, Surh Y-J. Protective effects of Silibinin on Helicobacter pylori-induced gastritis: NF-\u03baB and STAT3 as potential targets. J Cancer Prev. 2021;26(2):118.","journal-title":"J Cancer Prev"},{"key":"2448_CR12","doi-asserted-by":"publisher","first-page":"909223","DOI":"10.3389\/fcimb.2022.909223","volume":"12","author":"Y Mo","year":"2022","unstructured":"Mo Y, Ma J, Zhang H, Shen J, Chen J, Hong J, Xu Y, Qian C. Prophylactic and therapeutic HPV vaccines: current scenario and perspectives. Front Cell Infect Microbiol. 2022;12:909223.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2448_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13027-025-00643-5","volume":"20","author":"S Amiri","year":"2025","unstructured":"Amiri S, Rasekh S, Moezzi SMI, Seifi N, Fatemi SA, Fathi S, Bagheri A, Negahdaripour M. Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded. Infect Agents Cancer. 2025;20(1):16.","journal-title":"Infect Agents Cancer"},{"issue":"12","key":"2448_CR14","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3390\/vaccines11121862","volume":"11","author":"F Mahmood","year":"2023","unstructured":"Mahmood F, Xu R, Awan MUN, Song Y, Han Q, Xia X, Wei J, Xu J, Peng J, Zhang J. HBV vaccines: advances and development. Vaccines. 2023;11(12):1862.","journal-title":"Vaccines"},{"key":"2448_CR15","doi-asserted-by":"publisher","first-page":"205873842110026","DOI":"10.1177\/20587384211002621","volume":"35","author":"S Kausar","year":"2021","unstructured":"Kausar S, Said Khan F, Ishaq Mujeeb Ur Rehman M, Akram M, Riaz M, Rasool G, Hamid Khan A, Saleem I, Shamim S, Malik A. A review: mechanism of action of antiviral drugs. Int J ImmunoPathol Pharmacol. 2021;35:20587384211002621.","journal-title":"Int J ImmunoPathol Pharmacol"},{"issue":"13","key":"2448_CR16","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization States in the tumor microenvironment. Int J Mol Sci. 2021;22(13):6995.","journal-title":"Int J Mol Sci"},{"key":"2448_CR17","doi-asserted-by":"publisher","first-page":"101080","DOI":"10.1016\/j.drup.2024.101080","volume":"74","author":"G Che","year":"2024","unstructured":"Che G, Yin J, Wang W, Luo Y, Chen Y, Yu X, Wang H, Liu X, Chen Z, Wang X. Circumventing drug resistance in gastric cancer: a Spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics. Drug Resist Updates. 2024;74:101080.","journal-title":"Drug Resist Updates"},{"issue":"7","key":"2448_CR18","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1080\/08820139.2024.2367682","volume":"53","author":"CD Cerdeira","year":"2024","unstructured":"Cerdeira CD, Brigag\u00e3o MR. Targeting macrophage polarization in infectious diseases: M1\/M2 functional profiles, immune signaling and microbial virulence factors. Immunol Investig. 2024;53(7):1030\u201391.","journal-title":"Immunol Investig"},{"issue":"3","key":"2448_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/1040841X.2024.2366944","volume":"51","author":"X Fei","year":"2025","unstructured":"Fei X, Li N, Xu X, Zhu Y. Macrophage biology in the pathogenesis of Helicobacter pylori infection. Crit Rev Microbiol. 2025;51(3):399\u2013416.","journal-title":"Crit Rev Microbiol"},{"issue":"2","key":"2448_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000505522","volume":"87","author":"M Snietura","year":"2020","unstructured":"Snietura M, Brewczynski A, Kopec A, Rutkowski T. Infiltrates of M2-like tumour-associated macrophages are adverse prognostic factor in patients with human papillomavirus-negative but not in human papillomavirus-positive oropharyngeal squamous cell carcinoma. Pathobiology. 2020;87(2):75\u201386.","journal-title":"Pathobiology"},{"issue":"9","key":"2448_CR21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41419-020-02925-9","volume":"11","author":"B Zhang","year":"2020","unstructured":"Zhang B, Miao T, Shen X, Bao L, Zhang C, Yan C, Wei W, Chen J, Xiao L, Sun C. EB virus-induced ATR activation accelerates nasopharyngeal carcinoma growth via M2-type macrophages polarization. Cell Death Dis. 2020;11(9):742.","journal-title":"Cell Death Dis"},{"issue":"5","key":"2448_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.35772\/ghm.2024.01066","volume":"6","author":"T Tagawa","year":"2024","unstructured":"Tagawa T, Mahesh G, Ziegelbauer JM. Analysis of tumor infiltrating immune cells in Kaposi sarcoma lesions discovers shifts in macrophage populations. Global Health Med. 2024;6(5):310\u20135.","journal-title":"Global Health Med"},{"key":"2448_CR23","doi-asserted-by":"publisher","first-page":"839585","DOI":"10.3389\/fmicb.2022.839585","volume":"13","author":"S Yu","year":"2022","unstructured":"Yu S, Ge H, Li S, Qiu H-J. Modulation of macrophage polarization by viruses: turning off\/on host antiviral responses. Front Microbiol. 2022;13:839585.","journal-title":"Front Microbiol"},{"issue":"1","key":"2448_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/07853890.2022.2061045","volume":"54","author":"M Liang","year":"2022","unstructured":"Liang M, Liu Y, Zhang Z, Yang H, Dai N, Zhang N, Sun W, Guo Y, Kong J, Wang X. Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance. Ann Med. 2022;54(1):989\u20131003.","journal-title":"Ann Med"},{"issue":"8","key":"2448_CR25","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.62347\/MYZA2640","volume":"14","author":"M Luo","year":"2024","unstructured":"Luo M, Li Q, Gu Q, Zhang C. Fusobacterium nucleatum: a novel regulator of antitumor immune checkpoint Blockade therapy in colorectal cancer. Am J Cancer Res. 2024;14(8):3962.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"2448_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.gastro.2022.04.031","volume":"163","author":"L Ding","year":"2022","unstructured":"Ding L, Chakrabarti J, Sheriff S, Li Q, Hong HNT, Sontz RA, Mendoza ZE, Schreibeis A, Helmrath MA, Zavros Y. Toll-like receptor 9 pathway mediates Schlafen+-MDSC polarization during Helicobacter-induced gastric metaplasias. Gastroenterology. 2022;163(2):411\u201325. e414.","journal-title":"Gastroenterology"},{"issue":"2","key":"2448_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/cancers13020210","volume":"13","author":"M Haist","year":"2021","unstructured":"Haist M, Stege H, Grabbe S, Bros M. The functional crosstalk between myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment. Cancers. 2021;13(2):210.","journal-title":"Cancers"},{"issue":"3","key":"2448_CR28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/hep.32331","volume":"76","author":"S Pal","year":"2022","unstructured":"Pal S, Dey D, Chakraborty BC, Nandi M, Khatun M, Banerjee S, Santra A, Ghosh R, Ahammed SM, Chowdhury A. Diverse facets of MDSC in different phases of chronic HBV infection: impact on HBV-specific T\u2010cell response and homing. Hepatology. 2022;76(3):759\u201374.","journal-title":"Hepatology"},{"issue":"2","key":"2448_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tim.2022.08.010","volume":"31","author":"N Wang","year":"2023","unstructured":"Wang N, Fang J-Y. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer. Trends Microbiol. 2023;31(2):159\u201372.","journal-title":"Trends Microbiol"},{"issue":"1","key":"2448_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13046-023-02817-8","volume":"42","author":"X Kong","year":"2023","unstructured":"Kong X, Zhang Y, Xiang L, You Y, Duan Y, Zhao Y, Li S, Wu R, Zhang J, Zhou L. Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression. J Experimental Clin Cancer Res. 2023;42(1):236.","journal-title":"J Experimental Clin Cancer Res"},{"key":"2448_CR31","doi-asserted-by":"publisher","first-page":"1449539","DOI":"10.3389\/fcimb.2024.1449539","volume":"14","author":"M Muchova","year":"2024","unstructured":"Muchova M, Kuehne SA, Grant MM, Smith PP, Nagi M, Chapple IL, Hirschfeld J. Fusobacterium nucleatum elicits subspecies-specific responses in human neutrophils. Front Cell Infect Microbiol. 2024;14:1449539.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2448_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijms26010006","volume":"26","author":"H Masui","year":"2024","unstructured":"Masui H, Kawada K, Obama K. Neutrophil and colorectal cancer. Int J Mol Sci. 2024;26(1):6.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"2448_CR33","doi-asserted-by":"publisher","first-page":"10546","DOI":"10.3390\/ijms231810546","volume":"23","author":"HS Lee","year":"2022","unstructured":"Lee HS, Kim WJ. The role of matrix metalloproteinase in inflammation with a focus on infectious diseases. Int J Mol Sci. 2022;23(18):10546.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"2448_CR34","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.3390\/cancers13174495","volume":"13","author":"U Demkow","year":"2021","unstructured":"Demkow U. Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis. Cancers. 2021;13(17):4495.","journal-title":"Cancers"},{"issue":"4","key":"2448_CR35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ni.3375","volume":"17","author":"A Rivera","year":"2016","unstructured":"Rivera A, Siracusa MC, Yap GS, Gause WC. Innate cell communication kick-starts pathogen-specific immunity. Nat Immunol. 2016;17(4):356\u201363.","journal-title":"Nat Immunol"},{"issue":"8","key":"2448_CR36","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3390\/cells11081322","volume":"11","author":"L Chan","year":"2022","unstructured":"Chan L, Morovati S, Karimi N, Alizadeh K, Vanderkamp S, Kakish JE, Bridle BW, Karimi K. Neutrophil functional heterogeneity and implications for viral infections and treatments. Cells. 2022;11(8):1322.","journal-title":"Cells"},{"issue":"6","key":"2448_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41423-020-0465-0","volume":"17","author":"KL Hilligan","year":"2020","unstructured":"Hilligan KL, Ronchese F. Antigen presentation by dendritic cells and their instruction of CD4\u2009+\u2009T helper cell responses. Cell Mol Immunol. 2020;17(6):587\u201399.","journal-title":"Cell Mol Immunol"},{"key":"2448_CR38","doi-asserted-by":"crossref","unstructured":"Oth T, Vanderlocht J, Van Elssen C H, Bos G M, Germeraad W T. Pathogen-associated molecular patterns induced crosstalk between dendritic cells, T helper cells, and natural killer helper cells can improve dendritic cell vaccination. Mediat Inflamm. 2016;2016(1):5740373.","DOI":"10.1155\/2016\/5740373"},{"key":"2448_CR39","doi-asserted-by":"crossref","unstructured":"Azimi T, Nasser A, Shariati A, Shiadeh SM, Safari H, Alizade-Sani M, Taghipour A, Dehghan A. The possible role of pathogenic and non-pathogenic bacteria in initiation and exacerbation of Celiac disease; a comprehensive review. Curr Pharm Biotechnol. 2020;21(6):452\u201366.","DOI":"10.2174\/1389201021666191219160729"},{"key":"2448_CR40","doi-asserted-by":"crossref","unstructured":"Wirtz S, Becker C, Fantini MC, Nieuwenhuis EE, Tubbe I, Galle PR, Schild H-Jr, Birkenbach M, Blumberg RS, Neurath MF. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-\u03baB activation. J Immunol. 2005;174(5):2814\u201324.","DOI":"10.4049\/jimmunol.174.5.2814"},{"key":"2448_CR41","doi-asserted-by":"crossref","unstructured":"Neuper T, Frauenlob T, Sarajlic M, Posselt G, Wessler S, Horejs-Hoeck J. TLR2, TLR4 and TLR10 shape the cytokine and chemokine release of H. pylori-infected human DCs. Int J Mol Sci. 2020;21(11):3897.","DOI":"10.3390\/ijms21113897"},{"key":"2448_CR42","doi-asserted-by":"crossref","unstructured":"Owyang SY, Zhang M, El-Zaatari M, Eaton KA, Bishu S, Hou G, Grasberger H, Kao JY. Dendritic cell\u2010derived TGF\u2010\u03b2 mediates the induction of mucosal regulatory T\u2010cell response to Helicobacter infection essential for maintenance of immune tolerance in mice. Helicobacter 2020;25(6):e12763.","DOI":"10.1111\/hel.12763"},{"key":"2448_CR43","doi-asserted-by":"crossref","unstructured":"Oster P, Vaillant L, Riva E, McMillan B, Begka C, Truntzer C, Richard C, Leblond MM, Messaoudene M, Machremi E. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies. Gut. 2022;71(3):457\u201366.","DOI":"10.1136\/gutjnl-2020-323392"},{"issue":"1","key":"2448_CR44","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q, Geng S, Luo H, Wang W, Mo Y-Q, Luo Q, Wang L, Song G-B, Sheng J-P, Xu B. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct Target Therapy. 2024;9(1):266.","journal-title":"Signal Transduct Target Therapy"},{"issue":"2","key":"2448_CR45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","volume":"22","author":"NK Bj\u00f6rkstr\u00f6m","year":"2022","unstructured":"Bj\u00f6rkstr\u00f6m NK, Strunz B, Ljunggren H-G. Natural killer cells in antiviral immunity. Nat Rev Immunol. 2022;22(2):112\u201323.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2448_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12865-018-0247-y","volume":"19","author":"T Oth","year":"2018","unstructured":"Oth T, Habets TH, Germeraad WT, Zonneveld MI, Bos GM, Vanderlocht J. Pathogen recognition by NK cells amplifies the pro-inflammatory cytokine production of monocyte-derived DC via IFN-\u03b3. BMC Immunol. 2018;19(1):8.","journal-title":"BMC Immunol"},{"key":"2448_CR47","doi-asserted-by":"crossref","unstructured":"Peng P, Lou Y, Wang S, Wang J, Zhang Z, Du P, Zheng J, Liu P, Xu L. X. Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-\u03b3 to modulate antitumor T-cell response after cryo-thermal therapy. J Immunother Cancer 2022;10(12):e005769.","DOI":"10.1136\/jitc-2022-005769"},{"key":"2448_CR48","doi-asserted-by":"publisher","first-page":"887186","DOI":"10.3389\/fimmu.2022.887186","volume":"13","author":"M Sajid","year":"2022","unstructured":"Sajid M, Liu L, Sun C. The dynamic role of NK cells in liver cancers: role in HCC and HBV associated HCC and its therapeutic implications. Front Immunol. 2022;13:887186.","journal-title":"Front Immunol"},{"issue":"6","key":"2448_CR49","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/cancers13061414","volume":"13","author":"IA Montes-Mojarro","year":"2021","unstructured":"Montes-Mojarro IA, Fend F, Quintanilla-Martinez L. EBV and the pathogenesis of NK\/T cell lymphoma. Cancers. 2021;13(6):1414.","journal-title":"Cancers"},{"issue":"6","key":"2448_CR50","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/JLB.MR0718-300R","volume":"105","author":"E Zaghi","year":"2019","unstructured":"Zaghi E, Calvi M, Marcenaro E, Mavilio D, Di Vito C. Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy. J Leukoc Biol. 2019;105(6):1243\u201351.","journal-title":"J Leukoc Biol"},{"key":"2448_CR51","doi-asserted-by":"publisher","first-page":"104198","DOI":"10.1016\/j.micpath.2020.104198","volume":"144","author":"M Keikha","year":"2020","unstructured":"Keikha M, Ghazvini K, Eslami M, Yousefi B, Casseb J, Yousefi M, Karbalaei M. Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection. Microb Pathog. 2020;144:104198.","journal-title":"Microb Pathog"},{"issue":"17","key":"2448_CR52","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.3390\/ijms21176144","volume":"21","author":"FR Shepherd","year":"2020","unstructured":"Shepherd FR, McLaren JE. T cell immunity to bacterial pathogens: mechanisms of immune control and bacterial evasion. Int J Mol Sci. 2020;21(17):6144.","journal-title":"Int J Mol Sci"},{"key":"2448_CR53","doi-asserted-by":"crossref","unstructured":"Huo S, Luo Y, Deng R, Liu X, Wang J, Wang L, Zhang B, Wang F, Lu J, Li X. EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells. J Immunother Cancer 2020;8(2):e001588.","DOI":"10.1136\/jitc-2020-001588"},{"issue":"15","key":"2448_CR54","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1002\/cam4.3213","volume":"9","author":"J Wang","year":"2020","unstructured":"Wang J, Luo Y, Bi P, Lu J, Wang F, Liu X, Zhang B, Li X. Mechanisms of Epstein-Barr virus nuclear antigen 1 favor Tregs accumulation in nasopharyngeal carcinoma. Cancer Med. 2020;9(15):5598\u2013608.","journal-title":"Cancer Med"},{"issue":"5","key":"2448_CR55","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/cancers12051060","volume":"12","author":"JR Lechien","year":"2020","unstructured":"Lechien JR, Descamps G, Seminerio I, Furgiuele S, Dequanter D, Mouawad F, Badoual C, Journe F, Saussez S. HPV involvement in the tumor microenvironment and immune treatment in head and neck squamous cell carcinomas. Cancers. 2020;12(5):1060.","journal-title":"Cancers"},{"key":"2448_CR56","doi-asserted-by":"crossref","unstructured":"Wan Z, Zhou Z, Liu Y, Lai Y, Luo Y, Peng X, Zou W. Regulatory T cells and T helper 17 cells in viral infection. Scand J Immunol 2020;91(5):e12873.","DOI":"10.1111\/sji.12873"},{"issue":"5","key":"2448_CR57","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3390\/ijms21051705","volume":"21","author":"M Ciurkiewicz","year":"2020","unstructured":"Ciurkiewicz M, Herder V, Beineke A. Beneficial and detrimental effects of regulatory T cells in neurotropic virus infections. Int J Mol Sci. 2020;21(5):1705.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2448_CR58","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3390\/v14051017","volume":"14","author":"X Zheng","year":"2022","unstructured":"Zheng X, Huang Y, Li K, Luo R, Cai M, Yun J. Immunosuppressive tumor microenvironment and immunotherapy of epstein\u2013barr virus-associated malignancies. Viruses. 2022;14(5):1017.","journal-title":"Viruses"},{"key":"2448_CR59","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","volume":"11","author":"JM Jubel","year":"2020","unstructured":"Jubel JM, Barbati ZR, Burger C, Wirtz DC, Schildberg FA. The role of PD-1 in acute and chronic infection. Front Immunol. 2020;11:487.","journal-title":"Front Immunol"},{"key":"2448_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.celrep.2020.107827","volume":"31","author":"KE Pauken","year":"2020","unstructured":"Pauken KE, Godec J, Odorizzi PM, Brown KE, Yates KB, Ngiow SF, Burke KP, Maleri S, Grande SM, Francisco LM. The PD-1 pathway regulates development and function of memory CD8\u2009+\u2009T cells following respiratory viral infection. Cell Rep. 2020;31:13.","journal-title":"Cell Rep"},{"issue":"13\u201314","key":"2448_CR61","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1089\/hum.2023.227","volume":"35","author":"M Mu\u00f1oz-Melero","year":"2024","unstructured":"Mu\u00f1oz-Melero M, Biswas M. Role of FoxP3\u2009+\u2009regulatory T cells in modulating immune responses to adeno-associated virus gene therapy. Hum Gene Ther. 2024;35(13\u201314):439\u201350.","journal-title":"Hum Gene Ther"},{"issue":"3","key":"2448_CR62","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/10408363.2022.2157791","volume":"60","author":"S Ahmadi Ghezeldasht","year":"2023","unstructured":"Ahmadi Ghezeldasht S, Blackbourn DJ, Mosavat A, Rezaee SA. Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia\/lymphoma (ATLL). Crit Rev Clin Lab Sci. 2023;60(3):189\u2013211.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"7","key":"2448_CR63","doi-asserted-by":"publisher","first-page":"e539","DOI":"10.1016\/S2352-3026(23)00087-X","volume":"10","author":"JS O\u2019Donnell","year":"2023","unstructured":"O\u2019Donnell JS, Hunt SK, Chappell KJ. Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma. Lancet Haematol. 2023;10(7):e539\u201348.","journal-title":"Lancet Haematol"},{"key":"2448_CR64","doi-asserted-by":"crossref","unstructured":"Zuo X, Zhou R, Yang S, Ma G. HTLV-1 persistent infection and ATLL oncogenesis. J Med Virol 2023;95(1):e28424.","DOI":"10.1002\/jmv.28424"},{"issue":"6","key":"2448_CR65","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jmii.2019.09.005","volume":"53","author":"W-H Wang","year":"2020","unstructured":"Wang W-H, Lin C-Y, Chang MR, Urbina AN, Assavalapsakul W, Thitithanyanont A, Chen Y-H, Liu F-T, Wang S-F. The role of galectins in virus infection-A systemic literature review. J Microbiol Immunol Infect. 2020;53(6):925\u201335.","journal-title":"J Microbiol Immunol Infect"},{"key":"2448_CR66","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/JCI150472","volume":"131","author":"BJ Tan","year":"2021","unstructured":"Tan BJ, Sugata K, Reda O, Matsuo M, Uchiyama K, Miyazato P, Hahaut V, Yamagishi M, Uchimaru K, Suzuki Y. HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia\/lymphoma. J Clin Investig. 2021;131:24.","journal-title":"J Clin Investig"},{"issue":"10","key":"2448_CR67","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/v16101612","volume":"16","author":"J Echevarria-Lima","year":"2024","unstructured":"Echevarria-Lima J, Moles R. Monocyte and macrophage functions in oncogenic viral infections. Viruses. 2024;16(10):1612.","journal-title":"Viruses"},{"key":"2448_CR68","doi-asserted-by":"crossref","unstructured":"Viens LJ, Henley SJ, Watson M, Markowitz LE, Saraiya M. Human papillomavirus\u2013associated cancers\u2014United States, 2008\u20132012. MMWR Morb Mortal Wkly Rep. 2016;65(26):661.","DOI":"10.15585\/mmwr.mm6526a1"},{"issue":"3\u20134","key":"2448_CR69","first-page":"185","volume":"150","author":"G Gao","year":"2017","unstructured":"Gao G, Smith DI. Human papillomavirus and the development of different cancers. Cytogenet Genome Res. 2017;150(3\u20134):185\u201393.","journal-title":"Cytogenet Genome Res"},{"issue":"9590","key":"2448_CR70","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890\u2013907.","journal-title":"Lancet"},{"key":"2448_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-017-0541-1","volume":"36","author":"AC de Freitas","year":"2017","unstructured":"de Freitas AC, de Oliveira THA, Barros MR, Venuti A. HrHPV E5 oncoprotein: immune evasion and related immunotherapies. J Experimental Clin Cancer Res. 2017;36:1\u201315.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"4","key":"2448_CR72","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/v17040512","volume":"17","author":"VE Pereira Santos","year":"2025","unstructured":"Pereira Santos VE, de Fran\u00e7a S\u00e3o Marcos B, Fontes PHB, Silva ME, d. S, Le\u00e3o SL, da Silva GRP, Ribeiro DE, da Gama MAT. I. A. E5 oncoprotein: A key player in human Papillomavirus-Positive head and neck cancer pathogenesis and therapy resistance. Viruses. 2025;17(4):512. de Oliveira Is\u00eddio, B. E.; de Moura,.","journal-title":"Viruses"},{"key":"2448_CR73","first-page":"4495","volume":"13","author":"J Zhao","year":"2020","unstructured":"Zhao J, Yang T, Zhao M, Pei M, Yang X. Effects of endometrial cancer complicated with HPV infection on HE4 and Th1\/Th2 cytokines. Int J Clin Exp Med. 2020;13:4495\u2013500.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"2448_CR74","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41418-023-01242-w","volume":"31","author":"X Huang","year":"2024","unstructured":"Huang X, Huo L, Xiao B, Ouyang Y, Chen F, Li J, Zheng X, Wei D, Wu Y, Zhang R. Activating STING\/TBK1 suppresses tumor growth via degrading HPV16\/18 E7 oncoproteins in cervical cancer. Cell Death Differ. 2024;31(1):78\u201389.","journal-title":"Cell Death Differ"},{"key":"2448_CR75","doi-asserted-by":"publisher","first-page":"596825","DOI":"10.3389\/fimmu.2020.596825","volume":"11","author":"J Rotman","year":"2020","unstructured":"Rotman J, Otter LAd, Bleeker MC, Samuels SS, Heeren AM, Roemer MG, Kenter GG, Zijlmans HJ, van Trommel NE, de Gruijl T. D. PD-L1 and PD-L2 expression in cervical cancer: regulation and biomarker potential. Front Immunol. 2020;11:596825.","journal-title":"Front Immunol"},{"issue":"10","key":"2448_CR76","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/jog.13411","volume":"43","author":"W Yang","year":"2017","unstructured":"Yang W, Lu YP, Yang YZ, Kang JR, Jin YD, Wang HW. Expressions of programmed death (PD)-1 and PD\u20101 ligand (PD\u2010L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status. J Obstet Gynecol Res. 2017;43(10):1602\u201312.","journal-title":"J Obstet Gynecol Res"},{"issue":"9","key":"2448_CR77","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1097\/PAS.0000000000001506","volume":"44","author":"ME Dibbern","year":"2020","unstructured":"Dibbern ME, Bullock TN, Jenkins TM, Duska LR, Stoler MH, Mills AM. Loss of MHC class I expression in HPV-associated cervical and vulvar neoplasia: a potential mechanism of resistance to checkpoint Inhibition. Am J Surg Pathol. 2020;44(9):1184\u201391.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2448_CR78","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/hep.27969","volume":"62","author":"C de Martel","year":"2015","unstructured":"de Martel C, Maucort-Boulch D, Plummer M, Franceschi S. World\u2010wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015;62(4):1190\u2013200.","journal-title":"Hepatology"},{"key":"2448_CR79","first-page":"167","volume":"33","author":"D Shouval","year":"2013","unstructured":"Shouval D, Shibolet O. Immunosuppression and HBV reactivation. In Seminars in liver disease. Thieme Med Publishers. 2013;33:167\u201377.","journal-title":"Thieme Med Publishers"},{"issue":"8","key":"2448_CR80","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1136\/gutjnl-2022-327059","volume":"72","author":"C-Y Meng","year":"2023","unstructured":"Meng C-Y, Sun S, Liang Y, Xu H, Zhang C, Zhang M, Wang F-S, Fu Y-X, Peng H. Engineered anti-PDL1 with IFN\u03b1 targets both Immunoinhibitory and activating signals in the liver to break HBV immune tolerance. Gut. 2023;72(8):1544\u201354.","journal-title":"Gut"},{"key":"2448_CR81","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3389\/fimmu.2020.01037","volume":"11","author":"B Li","year":"2020","unstructured":"Li B, Yan C, Zhu J, Chen X, Fu Q, Zhang H, Tong Z, Liu L, Zheng Y, Zhao P. Anti\u2013PD-1\/PD-L1 Blockade immunotherapy employed in treating hepatitis B virus infection\u2013related advanced hepatocellular carcinoma: a literature review. Front Immunol. 2020;11:1037.","journal-title":"Front Immunol"},{"key":"2448_CR82","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/1874357901812010026","volume":"12","author":"A Petruzziello","year":"2018","unstructured":"Petruzziello A. Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma. Open Virol J. 2018;12:26.","journal-title":"Open Virol J"},{"issue":"22","key":"2448_CR83","doi-asserted-by":"publisher","first-page":"16100","DOI":"10.3390\/ijms242216100","volume":"24","author":"S Barik","year":"2023","unstructured":"Barik S. Suppression of innate immunity by the hepatitis C virus (HCV): revisiting the specificity of host\u2013virus interactive pathways. Int J Mol Sci. 2023;24(22):16100.","journal-title":"Int J Mol Sci"},{"key":"2448_CR84","doi-asserted-by":"publisher","first-page":"694145","DOI":"10.3389\/fonc.2021.694145","volume":"11","author":"S Bao","year":"2021","unstructured":"Bao S, Jiang X, Jin S, Tu P, Lu J. TGF-\u03b21 induces immune escape by enhancing PD-1 and CTLA-4 expression on T lymphocytes in hepatocellular carcinoma. Front Oncol. 2021;11:694145.","journal-title":"Front Oncol"},{"key":"2448_CR85","doi-asserted-by":"publisher","first-page":"760971","DOI":"10.3389\/fonc.2021.760971","volume":"11","author":"J Xu","year":"2021","unstructured":"Xu J, Lin H, Wu G, Zhu M, Li M. IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma. Front Oncol. 2021;11:760971.","journal-title":"Front Oncol"},{"issue":"6","key":"2448_CR86","doi-asserted-by":"publisher","first-page":"101538","DOI":"10.1016\/j.aohep.2024.101538","volume":"29","author":"J Xu","year":"2024","unstructured":"Xu J, Liu K, Gong Z, Liu J, Lin H, Lin B, Li W, Zhu M, Li M. IL-6\/STAT3 signaling pathway induces prostate apoptosis response protein-4 (PAR-4) to stimulate malignant behaviors of hepatocellular carcinoma cells. Ann Hepatol. 2024;29(6):101538.","journal-title":"Ann Hepatol"},{"issue":"1","key":"2448_CR87","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41467-020-20316-8","volume":"12","author":"L Zhou","year":"2021","unstructured":"Zhou L, He R, Fang P, Li M, Yu H, Wang Q, Yu Y, Wang F, Zhang Y, Chen A. Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition. Nat Commun. 2021;12(1):98.","journal-title":"Nat Commun"},{"issue":"5","key":"2448_CR88","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/vaccines13050496","volume":"13","author":"S Ying","year":"2025","unstructured":"Ying S, Liu H, Zhang Y, Mei Y. Harnessing dendritic cell function in hepatocellular carcinoma: advances in immunotherapy and therapeutic strategies. Vaccines. 2025;13(5):496.","journal-title":"Vaccines"},{"issue":"9","key":"2448_CR89","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/biom14091161","volume":"14","author":"W Li","year":"2024","unstructured":"Li W, Chen G, Peng H, Zhang Q, Nie D, Guo T, Zhu Y, Zhang Y, Lin M. Research progress on dendritic cells in hepatocellular carcinoma immune microenvironments. Biomolecules. 2024;14(9):1161.","journal-title":"Biomolecules"},{"key":"2448_CR90","doi-asserted-by":"crossref","unstructured":"Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein\u2013Barr virus-related cancers. J Cancer Res Clin Oncol 2022;148(1):31\u201346.","DOI":"10.1007\/s00432-021-03824-y"},{"issue":"2","key":"2448_CR91","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2174\/1568009623666230512153741","volume":"24","author":"X Huang","year":"2024","unstructured":"Huang X, Zhang M, Zhang Z. The role of LMP1 in Epstein-Barr virus-associated gastric cancer. Curr Cancer Drug Targets. 2024;24(2):127\u201341.","journal-title":"Curr Cancer Drug Targets"},{"issue":"21","key":"2448_CR92","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.3390\/cancers13215451","volume":"13","author":"L Wang","year":"2021","unstructured":"Wang L, Ning S. New look of EBV LMP1 signaling landscape. Cancers. 2021;13(21):5451.","journal-title":"Cancers"},{"issue":"7","key":"2448_CR93","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.3390\/cancers15072133","volume":"15","author":"DG Sausen","year":"2023","unstructured":"Sausen DG, Basith A, Muqeemuddin S. EBV and lymphomagenesis. Cancers. 2023;15(7):2133.","journal-title":"Cancers"},{"issue":"30","key":"2448_CR94","doi-asserted-by":"publisher","first-page":"e2200512119","DOI":"10.1073\/pnas.2200512119","volume":"119","author":"S Beer","year":"2022","unstructured":"Beer S, Wange LE, Zhang X, Kuklik-Roos C, Enard W, Hammerschmidt W, Scialdone A, Kempkes B. EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus\u2013infected B cells. Proc Natl Acad Sci. 2022;119(30):e2200512119.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"2448_CR95","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00432-024-05702-9","volume":"150","author":"J Chen","year":"2024","unstructured":"Chen J, Zhou J, Cheng F, Chen D, Guan F, Zhang E, He J, Cai Z, Zhao Y. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma. J Cancer Res Clin Oncol. 2024;150(4):181.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"16","key":"2448_CR96","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.3390\/cancers13164079","volume":"13","author":"JM Knerr","year":"2021","unstructured":"Knerr JM, Kledal TN, Rosenkilde MM. Molecular properties and therapeutic targeting of the EBV-encoded receptor BILF1. Cancers. 2021;13(16):4079.","journal-title":"Cancers"},{"issue":"10","key":"2448_CR97","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3390\/pathogens13100876","volume":"13","author":"N Todorovi\u0107","year":"2024","unstructured":"Todorovi\u0107 N, Ambrosio MR, Amedei A. Immune modulation by Epstein\u2013Barr virus lytic cycle: relevance and implication in oncogenesis. Pathogens. 2024;13(10):876.","journal-title":"Pathogens"},{"issue":"1","key":"2448_CR98","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12935-021-01793-3","volume":"21","author":"Y Luo","year":"2021","unstructured":"Luo Y, Liu Y, Wang C, Gan R. Signaling pathways of EBV-induced oncogenesis. Cancer Cell Int. 2021;21(1):93.","journal-title":"Cancer Cell Int"},{"issue":"17","key":"2448_CR99","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.3390\/cancers13174269","volume":"13","author":"A Markazi","year":"2021","unstructured":"Markazi A, Meng W, Bracci PM, McGrath MS, Gao S-J. The role of bacteria in KSHV infection and KSHV-induced cancers. Cancers. 2021;13(17):4269.","journal-title":"Cancers"},{"key":"2448_CR100","doi-asserted-by":"crossref","unstructured":"Blumenthal MJ, Cornejo Castro EM, Whitby D, Katz AA, Sch\u00e4fer G. Evidence for altered host genetic factors in KSHV infection and KSHV-related disease development. Rev Med Virol 2021;31(2):e2160.","DOI":"10.1002\/rmv.2160"},{"key":"2448_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-020-00317-4","volume":"15","author":"J Charostad","year":"2020","unstructured":"Charostad J, Nakhaie M, Dehghani A, Faghihloo E. The interplay between EBV and KSHV viral products and NF-\u03baB pathway in oncogenesis. Infect Agents Cancer. 2020;15:1\u201312.","journal-title":"Infect Agents Cancer"},{"issue":"10","key":"2448_CR102","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3390\/v12101097","volume":"12","author":"N Alomari","year":"2020","unstructured":"Alomari N, Totonchy J. Cytokine-targeted therapeutics for KSHV-associated disease. Viruses. 2020;12(10):1097.","journal-title":"Viruses"},{"issue":"12","key":"2448_CR103","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3390\/v16121900","volume":"16","author":"S Komaki","year":"2024","unstructured":"Komaki S, Inagaki T, Kumar A, Izumiya Y. The role of vIL-6 in KSHV-Mediated immune evasion and tumorigenesis. Viruses. 2024;16(12):1900.","journal-title":"Viruses"},{"issue":"1","key":"2448_CR104","doi-asserted-by":"publisher","first-page":"e03011","DOI":"10.1128\/mbio.03011-23","volume":"15","author":"L Chen","year":"2024","unstructured":"Chen L, Ding L, Wang X, Huang Y, Gao S-J. Activation of glucocorticoid receptor signaling inhibits KSHV-induced inflammation and tumorigenesis. Mbio. 2024;15(1):e03011\u201303023.","journal-title":"Mbio"},{"key":"2448_CR105","doi-asserted-by":"crossref","unstructured":"Bagn\u00e9ris C, Senthil Kumar SL, Baratchian M, Britt HM, Assafa TE, Thalassinos K, Collins MK, Barrett TE. Mechanistic insights into the activation of the IKK kinase complex by the Kaposi's sarcoma herpes virus oncoprotein vFLIP. J Biol Chem. 2022;298(6):102012.","DOI":"10.1016\/j.jbc.2022.102012"},{"issue":"3","key":"2448_CR106","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/v15030730","volume":"15","author":"LR Combs","year":"2023","unstructured":"Combs LR, Combs J, McKenna R, Toth Z. Protein degradation by gammaherpesvirus rtas: more than just viral transactivators. Viruses. 2023;15(3):730.","journal-title":"Viruses"},{"key":"2448_CR107","doi-asserted-by":"crossref","unstructured":"Li J, Zhang Y, Luo B. The programed death-1\/programed death ligand\u20101 axis and its potential as a therapeutic target for virus\u2010associated tumours. Rev Med Virol 2024;34(1):e2486.","DOI":"10.1002\/rmv.2486"},{"key":"2448_CR108","doi-asserted-by":"crossref","unstructured":"Szymula A, Samayoa-Reyes G, Ogolla S, Liu B, Li S, George A, Van Sciver N, Rochford R, Simas JP, Kaye KM. Macrophages drive KSHV B cell latency. Cell Rep. 2023;42(7):112767.","DOI":"10.1016\/j.celrep.2023.112767"},{"issue":"1","key":"2448_CR109","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner P, Camargo MC, El-Omar E, Liou J-M, Peek R, Schulz C, Smith SI, Suerbaum S. Helicobacter pylori infection. Nat Reviews Disease Primers. 2023;9(1):19.","journal-title":"Nat Reviews Disease Primers"},{"issue":"7","key":"2448_CR110","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41575-022-00591-0","volume":"19","author":"Y Zavros","year":"2022","unstructured":"Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma. Nat Reviews Gastroenterol Hepatol. 2022;19(7):451\u201367.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"1","key":"2448_CR111","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12223-023-01091-7","volume":"69","author":"B Baral","year":"2024","unstructured":"Baral B, Kandpal M, Ray A, Jana A, Yadav DS, Sachin K, Mishra A, Baig MS, Jha HC. Helicobacter pylori and Epstein-Barr virus infection in cell Polarity alterations. Folia Microbiol. 2024;69(1):41\u201357.","journal-title":"Folia Microbiol"},{"issue":"1","key":"2448_CR112","doi-asserted-by":"publisher","first-page":"e13058","DOI":"10.1111\/hel.13058","volume":"29","author":"Z Marzhoseyni","year":"2024","unstructured":"Marzhoseyni Z, Mousavi MJ, Ghotloo S. Helicobacter pylori antigens as immunomodulators of immune system. Helicobacter. 2024;29(1):e13058.","journal-title":"Helicobacter"},{"key":"2448_CR113","unstructured":"XU X, Yan H, XU Z, Zhou S, Lyu W. To investigate the effect of Helicobacter pylori infection on Hedgehog and NOX\/NF-\u03baB\/STAT1 signaling pathway in chronic atrophic gastritis from the perspective of Dampness-Heat induced blood stasis. World Sci Technol-Modernization Tradit Chin Med 2024;137\u201344."},{"key":"2448_CR114","doi-asserted-by":"crossref","unstructured":"Shi Y, Zheng H, Wang M, Ding S. Influence of Helicobacter pylori infection on PD-1\/PD\u2010L1 Blockade therapy needs more attention. Helicobacter 2022;27(2):e12878.","DOI":"10.1111\/hel.12878"},{"key":"2448_CR115","doi-asserted-by":"crossref","unstructured":"Jia K, Chen Y, Xie Y, Wang X, Hu Y, Sun Y, Cao Y, Zhang L, Wang Y, Wang Z. Helicobacter pylori and immunotherapy for Gastrointestinal cancer. Innovation. 2024;5(2):100561.","DOI":"10.1016\/j.xinn.2023.100561"},{"key":"2448_CR116","doi-asserted-by":"crossref","unstructured":"Xiang X, Wu Y, Li H, Li C, Yan L, Li Q. Plasmacytoid dendritic cell-derived type I interferon is involved in Helicobacter pylori infection-induced differentiation of Schlafen 4-expressing myeloid-derived suppressor cells. Infect Immun. 2021;89(11):e0040721.","DOI":"10.1128\/IAI.00407-21"},{"issue":"1\u20132","key":"2448_CR117","doi-asserted-by":"publisher","first-page":"105236","DOI":"10.1016\/j.micinf.2023.105236","volume":"26","author":"J Li","year":"2024","unstructured":"Li J, Li X, Zhang Z, Wang S, Huang X, Min L, Li P. Helicobacter pylori promotes gastric fibroblast proliferation and migration by expulsing Exosomal miR-124-3p. Microbes Infect. 2024;26(1\u20132):105236.","journal-title":"Microbes Infect"},{"issue":"4","key":"2448_CR118","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3390\/cells9041055","volume":"9","author":"J Baj","year":"2020","unstructured":"Baj J, Korona-G\u0142owniak I, Forma A, Maani A, Sitarz E, Rahnama-Hezavah M, Radzikowska E, Portincasa P. Mechanisms of the epithelial\u2013mesenchymal transition and tumor microenvironment in Helicobacter pylori-induced gastric cancer. Cells. 2020;9(4):1055.","journal-title":"Cells"},{"key":"2448_CR119","doi-asserted-by":"publisher","first-page":"1020583","DOI":"10.3389\/fcimb.2022.1020583","volume":"12","author":"S Ou","year":"2022","unstructured":"Ou S, Wang H, Tao Y, Luo K, Ye J, Ran S, Guan Z, Wang Y, Hu H, Huang R. Fusobacterium nucleatum and colorectal cancer: from phenomenon to mechanism. Front Cell Infect Microbiol. 2022;12:1020583.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"2448_CR120","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1111\/jgh.15361","volume":"36","author":"S Yamamoto","year":"2021","unstructured":"Yamamoto S, Kinugasa H, Hirai M, Terasawa H, Yasutomi E, Oka S, Ohmori M, Yamasaki Y, Inokuchi T, Harada K. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer. J Gastroenterol Hepatol. 2021;36(7):1869\u201376.","journal-title":"J Gastroenterol Hepatol"},{"key":"2448_CR121","doi-asserted-by":"publisher","first-page":"117932","DOI":"10.1016\/j.jep.2024.117932","volume":"328","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Huang Y, Hu Y, Yang Y, You F, Hu Q, Li X, Zhao Z. Banxia Xiexin Decoction delays colitis-to-cancer transition by inhibiting E-cadherin\/\u03b2-catenin pathway via Fusobacterium nucleatum FadA. J Ethnopharmacol. 2024;328:117932.","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"2448_CR122","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/microorganisms11092358","volume":"11","author":"P Pignatelli","year":"2023","unstructured":"Pignatelli P, Nuccio F, Piattelli A, Curia MC. The role of Fusobacterium nucleatum in oral and colorectal carcinogenesis. Microorganisms. 2023;11(9):2358.","journal-title":"Microorganisms"},{"key":"2448_CR123","doi-asserted-by":"publisher","first-page":"658681","DOI":"10.3389\/fimmu.2021.658681","volume":"12","author":"L Hu","year":"2021","unstructured":"Hu L, Liu Y, Kong X, Wu R, Peng Q, Zhang Y, Zhou L, Duan L. Fusobacterium nucleatum facilitates M2 macrophage polarization and colorectal carcinoma progression by activating TLR4\/NF-\u03ba B\/S100A9 cascade. Front Immunol. 2021;12:658681.","journal-title":"Front Immunol"},{"issue":"1","key":"2448_CR124","doi-asserted-by":"publisher","first-page":"1980347","DOI":"10.1080\/19490976.2021.1980347","volume":"13","author":"C Xu","year":"2021","unstructured":"Xu C, Fan L, Lin Y, Shen W, Qi Y, Zhang Y, Chen Z, Wang L, Long Y, Hou T. Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322\/CCL20 axis and M2 polarization. Gut Microbes. 2021;13(1):1980347.","journal-title":"Gut Microbes"},{"issue":"12","key":"2448_CR125","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1136\/gutjnl-2015-310101","volume":"65","author":"K Mima","year":"2016","unstructured":"Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65(12):1973\u201380.","journal-title":"Gut"},{"issue":"7","key":"2448_CR126","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3390\/cancers17071252","volume":"17","author":"K Kim","year":"2025","unstructured":"Kim K, Lee M, Shin Y, Lee Y, Kim T-J. Optimizing cancer treatment through gut Microbiome modulation. Cancers. 2025;17(7):1252.","journal-title":"Cancers"},{"issue":"7","key":"2448_CR127","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jamaoncol.2022.0494","volume":"8","author":"L Liu","year":"2022","unstructured":"Liu L, Shah K. The potential of the gut Microbiome to reshape the cancer therapy paradigm: a review. JAMA Oncol. 2022;8(7):1059\u201367.","journal-title":"JAMA Oncol"},{"key":"2448_CR128","doi-asserted-by":"publisher","first-page":"114295","DOI":"10.1016\/j.addr.2022.114295","volume":"185","author":"W Chen","year":"2022","unstructured":"Chen W, Zhu Y, Zhang Z, Sun X. Advances in Salmonella Typhimurium-based drug delivery system for cancer therapy. Adv Drug Deliv Rev. 2022;185:114295.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2448_CR129","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4068\/cmj.2016.52.3.173","volume":"52","author":"JH Zheng","year":"2016","unstructured":"Zheng JH, Min J-J. Targeted cancer therapy using engineered Salmonella typhimurium. Chonnam Med J. 2016;52(3):173\u201384.","journal-title":"Chonnam Med J"},{"key":"2448_CR130","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.canlet.2019.10.033","volume":"469","author":"Y Guo","year":"2020","unstructured":"Guo Y, Chen Y, Liu X, Min J-J, Tan W, Zheng JH. Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium. Cancer Lett. 2020;469:102\u201310.","journal-title":"Cancer Lett"},{"issue":"1","key":"2448_CR131","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1038\/s41467-024-47190-y","volume":"15","author":"H-Y Chen","year":"2024","unstructured":"Chen H-Y, Hsieh W-C, Liu Y-C, Li H-Y, Liu P-Y, Hsu Y-T, Hsu S-C, Luo A-C, Kuo W-C, Huang Y-J. Mitochondrial injury induced by a Salmonella genotoxin triggers the Proinflammatory senescence-associated secretory phenotype. Nat Commun. 2024;15(1):2778.","journal-title":"Nat Commun"},{"issue":"1","key":"2448_CR132","first-page":"1","volume":"42","author":"X He","year":"2025","unstructured":"He X, Guo J, Bai Y, Sun H, Yang J. Salmonella-based therapeutic strategies: improving tumor microenvironment and bringing new hope for cancer immunotherapy. Med Oncol. 2025;42(1):1\u201316.","journal-title":"Med Oncol"},{"issue":"10","key":"2448_CR133","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.3390\/pharmaceutics14102100","volume":"14","author":"RP Aganja","year":"2022","unstructured":"Aganja RP, Sivasankar C, Senevirathne A, Lee JH. Salmonella as a promising curative tool against cancer. Pharmaceutics. 2022;14(10):2100.","journal-title":"Pharmaceutics"},{"issue":"2","key":"2448_CR134","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/jcm10020205","volume":"10","author":"LL Santos","year":"2021","unstructured":"Santos LL, Santos J, Gouveia MJ, Bernardo C, Lopes C, Rinaldi G, Brindley PJ, Costa JM. C. D. Urogenital schistosomiasis\u2014history, pathogenesis, and bladder cancer. J Clin Med. 2021;10(2):205.","journal-title":"J Clin Med"},{"key":"2448_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-020-00331-6","volume":"15","author":"EC Mbanefo","year":"2020","unstructured":"Mbanefo EC, Agbo CT, Zhao Y, Lamanna OK, Thai KH, Karinshak SE, Khan MA, Fu C-L, Odegaard JI, Saltikova IV. IPSE, an abundant egg-secreted protein of the carcinogenic helminth schistosoma haematobium, promotes proliferation of bladder cancer cells and angiogenesis. Infect Agents Cancer. 2020;15:1\u201310.","journal-title":"Infect Agents Cancer"},{"key":"2448_CR136","doi-asserted-by":"crossref","unstructured":"Vazquez-Espinoza I. Schistosoma haematobium: A pathophysiological review from chronic infection to bladder cancer. Pathogens Assoc Dev Cancer Humans OMICs Immunol Pathophysiol Stud. 2024;269\u201382.","DOI":"10.1007\/978-3-031-62558-9_14"},{"key":"2448_CR137","doi-asserted-by":"crossref","unstructured":"Mbanefo EC, Fu C-L, Ho CP, Le L, Ishida K, Hammam O, Hsieh MH. Interleukin-4 signaling plays a major role in urogenital schistosomiasis-associated bladder pathogenesis. Infect Immun. 2020;88(3):10.1128\/iai.00669\u2009\u2013\u200900619.","DOI":"10.1128\/IAI.00669-19"},{"key":"2448_CR138","doi-asserted-by":"crossref","unstructured":"Mertelsmann AM, Bowers SF, Wright D, Maganga JK, Mazigo HD, Ndhlovu LC, Changalucha JM, Downs JA. Effects of schistosoma haematobium infection and treatment on the systemic and mucosal immune phenotype, gene expression and microbiome: A systematic review. PLoS Negl Trop Dis 2024;18(9):e0012456.","DOI":"10.1371\/journal.pntd.0012456"},{"issue":"13","key":"2448_CR139","doi-asserted-by":"publisher","first-page":"7216","DOI":"10.3390\/ijms22137216","volume":"22","author":"P Masamba","year":"2021","unstructured":"Masamba P, Kappo AP. Immunological and biochemical interplay between cytokines, oxidative stress and schistosomiasis. Int J Mol Sci. 2021;22(13):7216.","journal-title":"Int J Mol Sci"},{"key":"2448_CR140","doi-asserted-by":"crossref","unstructured":"Mohammed SA, Hetta HF, Zahran AM, Tolba ME, Attia RA, Behnsawy HM, Algammal AM, Batiha GE-S, Mohammed AQ, Ahmad AA. T cell subsets, regulatory T, regulatory B cells and Proinflammatory cytokine profile in schistosoma haematobium associated bladder cancer: first report from upper Egypt. PLoS Negl Trop Dis 2023;17(4):e0011258.","DOI":"10.1371\/journal.pntd.0011258"},{"key":"2448_CR141","doi-asserted-by":"crossref","unstructured":"Rather SA, Wani ZA, Mustafa RA, Bharti P, Kousar R, Ashraf MV, Ahmad S, Shah A, Khan MH. Carcinogenic parasites: insights into the epidemiology and possible mechanisms of cancer. Mutagenesis. 2025;geaf007.","DOI":"10.1093\/mutage\/geaf007"},{"key":"2448_CR142","doi-asserted-by":"crossref","unstructured":"Afrifa J, Ofori EG, Opoku YK, Asare KK, Sorkpor RD, Naveh-Fio IW, Armah R, Ofori S, Ephraim RK. Oxidative Stress and Cancer Risk in Schistosomiasis. Oxidative Medicine and Cellular Longevity 2024;2024(1):9701021.","DOI":"10.1155\/omcl\/9701021"},{"issue":"6","key":"2448_CR143","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/pathogens12060795","volume":"12","author":"MYQ Liau","year":"2023","unstructured":"Liau MYQ, Toh EQ, Shelat VG. Opisthorchis viverrini\u2014current Understanding of the neglected hepatobiliary parasite. Pathogens. 2023;12(6):795.","journal-title":"Pathogens"},{"key":"2448_CR144","doi-asserted-by":"crossref","unstructured":"Chaiyadet S, Tangkawattana S, Smout MJ, Ittiprasert W, Mann VH, Deenonpoe R, Arunsan P, Loukas A, Brindley PJ, Laha T. Knockout of liver fluke granulin, Ov-grn-1, impedes malignant transformation during chronic infection with opisthorchis Viverrini. PLoS Pathog 2022;18(9):e1010839.","DOI":"10.1371\/journal.ppat.1010839"},{"key":"2448_CR145","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00436-020-06640-4","volume":"119","author":"N Vale","year":"2020","unstructured":"Vale N, Gouveia MJ, G\u00e4rtner F, Brindley PJ. Oxysterols of helminth parasites and pathogenesis of foodborne hepatic trematodiasis caused by opisthorchis and fasciola species. Parasitol Res. 2020;119:1443\u201353.","journal-title":"Parasitol Res"},{"key":"2448_CR146","doi-asserted-by":"crossref","unstructured":"Kafle A, Suttiprapa S, Muhammad M, Tenorio JCB, Mahato RK, Sahimin N, Loong SK. Epigenetic biomarkers and the Wnt\/\u03b2-Catenin pathway in opisthorchis viverrini-associated cholangiocarcinoma: A scoping review on therapeutic opportunities. PLoS Negl Trop Dis 2024;18(9):e0012477.","DOI":"10.1371\/journal.pntd.0012477"},{"key":"2448_CR147","doi-asserted-by":"publisher","first-page":"102401","DOI":"10.1016\/j.parint.2021.102401","volume":"84","author":"S Jittimanee","year":"2021","unstructured":"Jittimanee S, Wongratanacheewin S, Kaewraemruaen C, Jittimanee J. Opisthorchis Viverrini antigens up-regulates the expression of CD80 and MHC class II in JAWSII mouse dendritic cells and promotes IL-10 and TGF-\u03b2 secretions. Parasitol Int. 2021;84:102401.","journal-title":"Parasitol Int"},{"issue":"9","key":"2448_CR148","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/13543784.2021.1955102","volume":"30","author":"W Loilome","year":"2021","unstructured":"Loilome W, Dokduang H, Suksawat M, Padthaisong S. Therapeutic challenges at the preclinical level for targeted drug development for opisthorchis viverrini-associated cholangiocarcinoma. Expert Opin Investig Drugs. 2021;30(9):985\u20131006.","journal-title":"Expert Opin Investig Drugs"},{"key":"2448_CR149","doi-asserted-by":"crossref","unstructured":"Kim H-D, Kim S-Y, Lee H, Lee Y, Hyung J, Moon M, Shin J, Park YS, Ryu M-H. Predictive value of EBV-positivity in patients with gastric cancer treated with first-line nivolumab plus chemotherapy. Gastric Cancer. 2025;28(4):1\u201310.","DOI":"10.1007\/s10120-025-01618-6"},{"issue":"1","key":"2448_CR150","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1186\/s12885-023-11298-z","volume":"23","author":"Y-H Chen","year":"2023","unstructured":"Chen Y-H, Tsai C-H, Chen Y-Y, Wang C-C, Wang J-H, Hung C-H, Kuo Y-H. Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma. BMC Cancer. 2023;23(1):810.","journal-title":"BMC Cancer"},{"key":"2448_CR151","doi-asserted-by":"crossref","unstructured":"Pu D, Yin L, Zhou Y, Li W, Huang L, Cai L, Zhou Q. Safety and efficacy of immune checkpoint inhibitors in patients with HBV\/HCV infection and advanced-stage cancer: a systematic review. Medicine. 2020;99(5):e19013.","DOI":"10.1097\/MD.0000000000019013"},{"key":"2448_CR152","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11904-020-00525-y","volume":"17","author":"K Lurain","year":"2020","unstructured":"Lurain K, Ramaswami R, Yarchoan R, Uldrick TS. Anti-PD-1 and anti-PD-L1 monoclonal antibodies in people living with HIV and cancer. Curr HIV\/AIDS Rep. 2020;17:547\u201356.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"2448_CR153","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/v15010176","volume":"15","author":"M Salnikov","year":"2023","unstructured":"Salnikov M, Prusinkiewicz MA, Lin S, Ghasemi F, Cecchini MJ, Mymryk JS. Tumor-infiltrating T cells in EBV-associated gastric carcinomas exhibit high levels of multiple markers of activation, effector gene expression, and exhaustion. Viruses. 2023;15(1):176.","journal-title":"Viruses"},{"key":"2448_CR154","doi-asserted-by":"publisher","first-page":"1250946","DOI":"10.3389\/fimmu.2023.1250946","volume":"14","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xu M. EBV-induced T-cell responses in EBV-specific and nonspecific cancers. Front Immunol. 2023;14:1250946.","journal-title":"Front Immunol"},{"issue":"2","key":"2448_CR155","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11684-023-1032-8","volume":"18","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhou X, Zhang S, Wang N, Zhang T, Zhang D, Ao Q, Cao Y, Huang L. EBV-associated lymphoproliferative disease post-CAR-T cell therapy. Front Med. 2024;18(2):394\u20138.","journal-title":"Front Med"},{"issue":"10","key":"2448_CR156","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12032-023-02166-8","volume":"40","author":"A Letafati","year":"2023","unstructured":"Letafati A, Soheili R, Norouzi M, Soleimani P, Mozhgani S-H. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia\/lymphoma: a comprehensive review. Med Oncol. 2023;40(10):295.","journal-title":"Med Oncol"},{"issue":"5","key":"2448_CR157","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/biom15050715","volume":"15","author":"A Guglielmo","year":"2025","unstructured":"Guglielmo A, Borghi A, Zengarini C, Piraccini BM, Corazza M, Pileri A. OX40\u2013OX40L axis in cutaneous T-Cell lymphomas: pathogenic, prognostic, and potential therapeutic perspectives. Biomolecules. 2025;15(5):715.","journal-title":"Biomolecules"},{"issue":"11","key":"2448_CR158","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/biomedicines9111566","volume":"9","author":"CR Pangilinan","year":"2021","unstructured":"Pangilinan CR, Lee C-H. Highlights of Immunomodulation in Salmonella-based cancer therapy. Biomedicines. 2021;9(11):1566.","journal-title":"Biomedicines"},{"key":"2448_CR159","unstructured":"P\u00e9rez AM. Bacteria-instructed lymphocytes as a new generation of Immuno therapies against cancer. Universidad Aut\u00f3noma de Madrid; 2025."},{"key":"2448_CR160","doi-asserted-by":"crossref","unstructured":"Cho YS, Han K, Xu J, Moon JJ. Novel strategies for modulating the gut Microbiome for cancer therapy. Adv Drug Deliv Rev. 2024;115332.","DOI":"10.1016\/j.addr.2024.115332"},{"issue":"6","key":"2448_CR161","doi-asserted-by":"publisher","first-page":"C1433","DOI":"10.1152\/ajpcell.00201.2024","volume":"327","author":"S Ciernikova","year":"2024","unstructured":"Ciernikova S, Sevcikova A, Mego M. Targeting the gut and tumor Microbiome in cancer treatment resistance. Am J Physiology-Cell Physiol. 2024;327(6):C1433\u201350.","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"4","key":"2448_CR162","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/08830185.2024.2312294","volume":"43","author":"M Khan","year":"2024","unstructured":"Khan M, Shah S, Shah W, Khan I, Ali H, Ali I, Ullah R, Wang X, Mehmood A, Wang Y. Gut Microbiome as a treatment in colorectal cancer. Int Rev Immunol. 2024;43(4):229\u201347.","journal-title":"Int Rev Immunol"},{"issue":"1","key":"2448_CR163","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-023-01408-5","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang S, Liang B, Wang W, Li L, Feng N, Zhao Y, Wang T, Yan F, Yang S, Xia X. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases. Signal Transduct Target Therapy. 2023;8(1):149.","journal-title":"Signal Transduct Target Therapy"},{"key":"2448_CR164","doi-asserted-by":"crossref","unstructured":"Xi H. A Frontier in EBV Vaccine Research: mRNA-Based Immunization with gp350, gp42, and gL Glycoproteins. Scholarly Rev J. 2024;(9):104\u201313.","DOI":"10.70121\/001c.121730"},{"key":"2448_CR165","doi-asserted-by":"publisher","first-page":"867918","DOI":"10.3389\/fimmu.2022.867918","volume":"13","author":"GM Escalante","year":"2022","unstructured":"Escalante GM, Mutsvunguma LZ, Muniraju M, Rodriguez E, Ogembo JG. Four decades of prophylactic EBV vaccine research: a systematic review and historical perspective. Front Immunol. 2022;13:867918.","journal-title":"Front Immunol"},{"issue":"7","key":"2448_CR166","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/mc.23190","volume":"59","author":"S Tabachnick-Cherny","year":"2020","unstructured":"Tabachnick-Cherny S, Pulliam T, Church C, Koelle DM, Nghiem P. Polyomavirus\u2010driven Merkel cell carcinoma: prospects for therapeutic vaccine development. Mol Carcinog. 2020;59(7):807\u201321.","journal-title":"Mol Carcinog"},{"issue":"5","key":"2448_CR167","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"S Jhunjhunwala","year":"2021","unstructured":"Jhunjhunwala S, Hammer C, Delamarre L. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer. 2021;21(5):298\u2013312.","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"2448_CR168","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.3390\/ijms21228627","volume":"21","author":"JK Hwang","year":"2020","unstructured":"Hwang JK, Hong J, Yun C-O. Oncolytic viruses and immune checkpoint inhibitors: preclinical developments to clinical trials. Int J Mol Sci. 2020;21(22):8627.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2448_CR169","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12935-022-02585-z","volume":"22","author":"A Mardi","year":"2022","unstructured":"Mardi A, Shirokova AV, Mohammed RN, Keshavarz A, Zekiy AO, Thangavelu L, Mohamad TAM, Marofi F, Shomali N, Zamani A. Biological causes of Immunogenic cancer cell death (ICD) and anti-tumor therapy; combination of oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction. Cancer Cell Int. 2022;22(1):168.","journal-title":"Cancer Cell Int"},{"key":"2448_CR170","doi-asserted-by":"crossref","unstructured":"Zhang F, Li W, Zheng X, Ren Y, Li L, Yin H. The novel immune landscape of immune-checkpoint Blockade in EBV\u2010associated malignancies. FASEB J 2024;38(21):e70139.","DOI":"10.1096\/fj.202301980RR"},{"key":"2448_CR171","doi-asserted-by":"publisher","first-page":"216121","DOI":"10.1016\/j.canlet.2023.216121","volume":"559","author":"B Moran","year":"2023","unstructured":"Moran B, Davern M, Reynolds JV, Donlon NE, Lysaght J. The impact of histone deacetylase inhibitors on immune cells and implications for cancer therapy. Cancer Lett. 2023;559:216121.","journal-title":"Cancer Lett"},{"issue":"3","key":"2448_CR172","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/cancers14030552","volume":"14","author":"B Wu","year":"2022","unstructured":"Wu B, Sodji QH, Oyelere AK. Inflammation, fibrosis and cancer: mechanisms, therapeutic options and challenges. Cancers. 2022;14(3):552.","journal-title":"Cancers"},{"issue":"2","key":"2448_CR173","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.ymthe.2021.09.013","volume":"30","author":"Q Li","year":"2022","unstructured":"Li Q, Zhou Z-W, Lu J, Luo H, Wang S-N, Peng Y, Deng M-S, Song G-B, Wang J-M, Wei X. PD-L1P146R is prognostic and a negative predictor of response to immunotherapy in gastric cancer. Mol Ther. 2022;30(2):621\u201331.","journal-title":"Mol Ther"},{"key":"2448_CR174","doi-asserted-by":"publisher","first-page":"135369","DOI":"10.1016\/j.cej.2022.135369","volume":"437","author":"Q Li","year":"2022","unstructured":"Li Q, Luo H, Luo Y-Y, Zhang W, Hong H-M, Deng M-S, Wang Y, Xu B, Song G-B, Xu C-X. Plumbagin-loaded ZIF-90 nanoparticles suppress gastric cancer progression by targeting the YAP1 signaling. Chem Eng J. 2022;437:135369.","journal-title":"Chem Eng J"},{"issue":"11","key":"2448_CR175","doi-asserted-by":"publisher","first-page":"2203573","DOI":"10.1002\/advs.202203573","volume":"10","author":"Q Li","year":"2023","unstructured":"Li Q, Luo H, Dai FQ, Wang RT, Fan XQ, Luo YY, Deng MS, Wang Y, Long T, Guo W. SAMD9 promotes postoperative recurrence of esophageal squamous cell carcinoma by stimulating MYH9-mediated GSK3\u03b2\/\u03b2\u2010catenin signaling. Adv Sci. 2023;10(11):2203573.","journal-title":"Adv Sci"},{"issue":"26","key":"2448_CR176","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/s41388-024-03050-z","volume":"43","author":"J Song","year":"2024","unstructured":"Song J, Zhang J, Shi Y, Gao Q, Chen H, Ding X, Zhao M, Zhu C, Liang L, Sun X. Hypoxia inhibits ferritinophagy-mediated ferroptosis in esophageal squamous cell carcinoma via the USP2-NCOA4 axis. Oncogene. 2024;43(26):2000\u201314.","journal-title":"Oncogene"},{"issue":"1","key":"2448_CR177","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12943-024-02201-w","volume":"23","author":"H Luo","year":"2024","unstructured":"Luo H, Hu B, Gu X-R, Chen J, Fan X-Q, Zhang W, Wang R-T, He X-D, Guo W, Dai N. The miR-23a\/27a\/24\u2009\u2013\u20092 cluster drives immune evasion and resistance to PD-1\/PD-L1 Blockade in non-small cell lung cancer. Mol Cancer. 2024;23(1):285.","journal-title":"Mol Cancer"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02448-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02448-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02448-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T14:03:54Z","timestamp":1759413834000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02448-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":177,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2448"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02448-x","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}